Industry: Manufacturing Region: Austria Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
An Austrian company, established in 2009, provides GMP manufacturing services. Since 2019, the company has been focusing on becoming a contract development and manufacturing organization (CDMO). They specialize in helping other companies to produce key components such as plasmid DNA, mRNA and recombinant protein, and become important partners of biotechnology enterprises.
Services provided by enterprises:
1.GMP production company is committed to meeting customers' demands for clinical and market-supplied microbial drugs and pharmaceutical products, and has many years of successful experience in GMP production of plasmids and recombinant proteins. Has two fully integrated production bases, equipped with advanced biological processing facilities.
2. Aseptic filling company provides sterile filling and completion services that meet cGMP standards for DNA, protein and RNA. In addition, the company also provides culture medium filling verification services, drug product filling and completion process, formula development and other services.
3. Personalized manufacturing companies use efficient platform processes to produce plasmid DNA vaccines for specific patients. Personalized vaccine is a new treatment method in clinical development. In particular, DNA vaccine based on patient-specific tumor antigen is a promising solution to cure cancer patients.
Cooperation mode:
To seek China's partners who need plasmid DNA production and manufacturing services in the fields of biotechnology and pharmacy.